Comments
Glaxo melanoma drug combo shows promise in small trial
17.05.2012. | (Reuters) - Two drugs being developed by GlaxoSmithKline Plc - each designed to block different pathways used by cancer cells - have been shown in a small clinical trial to curb melanoma with fewer side effects than current therapies....
